Skip to main content
. 2023 Feb 21;7:e2200621. doi: 10.1200/PO.22.00621

FIG 1.

FIG 1.

(A) Prevalence of synchronous brain metastases at stage IV diagnosis in patients with KRAS-mutant NSCLC. (B) Kaplan-Meier estimates of OS of patients with stage IV KRAS-mutant NSCLC by presence of synchronous brain metastases at diagnosis. NSCLC, non–small-cell lung cancer; OS, overall survival.